Sublingual Ketamine as Breakthrough Analgesia in Patients with Advanced Cancer-A Feasibility Randomised Controlled Repeated Cross-over Trial (Lee, et al, 2025) "Ketamine scored higher than placebo for pain reduction, perceived to be more efficacious than usual breakthrough analgesia, and increased quality-of-life scores.” https://pubmed.ncbi.nlm.nih.gov/40650554/ #ketamine #psychedelics #cancer #painmanagement #ketaminetherapy
